In our final video from the LSX World Congress in Lisbon, Portugal, web editor Nicole Raleigh spoke with Paulo Neves, CMO of ...

When Kailera revealed its plans for an IPO last month, there was a feeling that it could be huge – and that expectation has ...

In its announcement, OpenAI called GPT-Rosalind a "frontier reasoning model built to support research across biology, drug ...

The months-long absence of permanent leadership at the CDC could soon be at an end, after President Trump nominated former ...

The revitalisation of GSK's Blenrep has continued with the news that the NHS in England can use the BCMA-targeting multiple ...

In September last year, we reported Servier had advanced its emerging neurology pipeline into the clinical trials stage by ...

The finding suggests the government has met its target of getting UK clinical trials up and running within an average of 150 ...

The ABPI, in the 3 rd March blog by Pinchas Kahtan, highlighted “early signs of a modest recovery in clinical trial ...

The British Business Bank (BB) has agreed to make a £100 million investment in a new healthcare fund launched by London-based ...

Saqib Islam, chief executive Officer of newly launched Beeline Medicines. The pace of private financing in biopharma steps up ...

A review of clinical data on amyloid beta-targeting Alzheimer's disease therapies has concluded their efficacy is too modest ...

Axtria Inc., a global leader in AI-first data analytics solutions for the life sciences industry, today announced the ...